Human CD138 ELISA kit
Product Specifications
- Catalogue N°
- 950.640.048 - 1 x 48 Discovery (pre-coated)
950.640.096 - 1 x 96 (pre-coated)
950.640.192 - 2 x 96 (pre-coated) - Assay Range
- 8 ng/ml - 256 ng/ml
- Sensitivity
- 4.94 ng/ml
- Target species
- Human
- Specificity
- Recognizes natural human soluble syndecan-1
- Incubation
- 1h45
- Sample Type
- Serum, Plasma, Cell culture supernatant
- Sample Size
- 100 µl
- Cross Reaction
- No cross reactivity with other human soluble molecules
- Kit Content
- Diaclone ELISA Kits include pre-coated strip plates, biotinylated secondary antibody, standards, controls (where applicable), buffers, streptavidin-HRP, TMB, stop reagents and a detailed procedure.
- Synonym
- SYNDECAN-1
References
- Kristensen, I.B. et al., Blood (ASH Annual Meeting Abstracts),2012;120:3977
- Kyrtsonis M-C. et al., Blood, 2004; 104(11): 4882
- Kyrtsonis, M.-C. et al., Blood (ASH Annual Meeting Abstracts),2005;106(11): 3404.
- Aachmann-Andersen,N.J. et al.,Physiol Rep. 2018 Mar;6(5):e13573 - Pubmed link
- Adepu, S. et al., Am J Physiol Renal Physiol.,2015; 309(2): F137-145 - Pubmed link
- Andersen, N.F. et al.,Br J Haematol.,2005;128:210-217 - Pubmed link
- Annecke, T. et al., Br. J. Anaesth.,2010;104(4): 414-421 - Pubmed link
- Benad-Mehner, P. et al., J Bone Oncol,,2014; 3(1): 18-24 - Pubmed link
- Bøe,O.W. et al.,Am J Case Rep.,2018 Feb 16;19:176-182. - Pubmed link
- Bruegger D. et al., Am J Physiol Heart Circ Physiol, 2005; 289(5):H1993-9 - Pubmed link
- Bruegger, D. et al., J. Thorac. Cardiovasc. Surg.,2009;138(6): 1445-1447. - Pubmed link
- Cekic, C. et al., Gastroenterol Res Pract.,2015: 850351 - Pubmed link
- Celie, J. W. A. M. et al., Am J Physiol Renal Physiol.,2008; 294(1): F253-263. - Pubmed link
- Chappell, D. et al.,Crit Care,2014; 18(5): 538 - Pubmed link
- Chappell, D.et al., Cardiovasc Res.,2009; 83(2): 388-396. - Pubmed link
- Cigliana, G. et al.,J Exp Clin Cancer Res., 2015;34(1):37 - Pubmed link
- Connolly-Andersen, A.-M. et al.,Open Forum Infect Dis.,2014; 1(1): ofu027- - Pubmed link
- Dogne, S. et al., Diabetes,2016;65(9):2742-2753 - Pubmed link
- Donati, A. et al., Crit Care,2014; 18(1): R33 - Pubmed link
- Gandley, R. E. et al., PLoS One,2016; 11(6): e0157608 - Pubmed link
- Hahn, R. G. et al., PLoS One,2016; 11(10): e0164152 - Pubmed link
- Haywood-Watson, R. J. et al.,PLoS One,2011;6(8): e23530 - Pubmed link
- Hofmann-Kiefer, K. F. et al., Reproductive Sciences, 2013; 20:318-325 - Pubmed link
- Iwata, H. et al., Haematologica,2004; 89(3): 368-370. - Pubmed link
- Janosi, J. et al., Haematologica,2004; 89(3): 370-371. - Pubmed link
- Jilani I. et al.,Int J Lab Hematol.,2009; 31:97-105 - Pubmed link
- Joensuu H. et al., Cancer Res., 2002; 62(18): 5210-7 - Pubmed link
- Johansson, L. et al., J Immunol.,2005; 175(1): 433-40 - Pubmed link
- Johansson, P. I. et al., Ann Surg.,2016; 265(3): 597-603. - Pubmed link
- Johansson, P. I. et al., Front Physiol.2014; 5: 459 - Pubmed link
- Johansson, P. I. et al., J Emerg Trauma Shock,2013;6(3):171-5 - Pubmed link
- Johansson, P. I. et al., PLoS One,2015; 10(3): e0120914 - Pubmed link
- Johansson, P. I. et al.,Crit Care,2011; 15(6): R272 - Pubmed link
- Kamat, P. et al., J Inflamm.(Lond),2012; 9(1): 18. - Pubmed link
- Kim, J. M. et al.,Korean J Hematol.,2010; 45(2): 115-9 - Pubmed link
- Kliment, C. R. et al., J. Biol. Chem.,2009; 284(6): 3537-3545. - Pubmed link
- le Poole, C. Y. et al.,Perit Dial Int.,2012; 32(3): 305-15 - Pubmed link
- Liu, X.Y. et al.,Front Physiol., 2018 Feb 22;9:102. - Pubmed link
- Long, D. S. et al., BMJ Open,2016; 6(12): e011244. - Pubmed link
- Lovell R. et al.,Br J Haematol.,2005; 130:542-548 - Pubmed link
- Mahtouk, K. et al., Blood,2007;109: 4914 - 4923 - Pubmed link
- Maisnar V. et al., Neoplasma.2006;53:26-29 - Pubmed link
- Meuwese, M. C. et al., J. Lipid Res.,2008; P800025-JLR200. - Pubmed link
- Molica, S. et al., Adv Hematol.,2009: 287974 - Pubmed link
- Molica, S. et al., Leuk Lymphoma, 2006; 47(6): 1034-40. - Pubmed link
- Mundt, F. et al., Biomed Res Int.,2014:419853 - Pubmed link
- Mundt, F. et al.,PLoS One,2013; 8(8): e72030 - Pubmed link
- Nault, J.-C. et al., Cancer Epidemiol. Biomarkers Prev.,2013; 22(8): 1343-1352. - Pubmed link
- Nemme, J. et al.,BMC Anesthesiol. 2017 Aug 22;17(1):107 - Pubmed link
- Ostrowski, S. R. et al., Crit Care,2013; 17(1): R32 - Pubmed link
- Ostrowski, S. R. et al., Crit Care,2015; 19:191 - Pubmed link
- Ostrowski, S. R. et al., Scand J Trauma Resusc Emerg Med.,2012; 20: 27. - Pubmed link
- Peterfia, B. et al.,PLoS One,2012; 7(6): e39474 - Pubmed link
- Qing, Q. et al., J Cell Mol Med.,2015;19(6): 1366-74 - Pubmed link
- Rehm, M. et al., Circulation,2007; 116(17): 1896-1906. - Pubmed link
- Ronsholt, F. F. et al., BMC Infect Dis,,2015; 15: 388. - Pubmed link
- Rossi, J. F. et al., Br J Cancer,2009; 101(7): 1051-8. - Pubmed link
- Schaar, C. G. et al., Haematologica,2005; 90(10): 1437-1438. - Pubmed link
- Schierke, F. et al.,Sci Rep. 2017 Apr 13;7:46476. - Pubmed link
- Seidel C. et al., Blood, 2000; 95(2): 388 - 392 - Pubmed link
- Snoeijs, M. G. et al., Am J Physiol Renal Physiol.,2010; 299(5): F1134-1140. - Pubmed link
- Suwarto, S. et al.,J Infect Dis. 2017 Mar 15;215(6):992-999. - Pubmed link
- Szarvas T. et al.,Hum Pathol.,2014;45:674-682 - Pubmed link
- Theocharis, A. D. et al., J Biol Chem.,2006; 281(46): 35116-28. - Pubmed link
- Thiara, A. S. et al, Perfusion,2010; 25(1): 9-16 - Pubmed link
- Thiara, A. S. et al., Perfusion,2011; 26(2): 107-114 - Pubmed link
- Vassilakopoulos T.P. et al.,Anticancer Res.,2005;25:4743-4746 - Pubmed link
- Vlahu, C. A. et al.,J. Am. Soc. Nephrol., 2012; 23: 1900-1908 - Pubmed link
- Wang X. et al., Br J Cancer.,2014;111:1965-1976 - Pubmed link
- Wolowiec, D. et al.,Mediators Inflamm., 2006(3): 42394. - Pubmed link
- Yamaguchi, M. et al.,Virulence. 2017 Nov 17;8(8):1516-1524. - Pubmed link
- Zausig, Y. A. et al.,Crit Care,2013; 17(5): R203 - Pubmed link
- Zvibel, I. et al., Liver Int.,2009;29(2):208-12 - Pubmed link
- Berthelsen, RE. Et al., Crit Care. 2019 Sep 5;23(1): 301 - Pubmed link
- Bogner-Flatz, V. et al., Mediators Inflamm. 2019; 2019: 8071619. - Pubmed link
- Fisher, J. et al.,Intensive Care Med Exp. 2019 Jan 7;7(1):2. - Pubmed link
- Gonzalez Rodriguez, E. et al.,Scand J Trauma Resusc Emerg Med. 2018 Nov 21;26(1):102. - Pubmed link
- Oda, K. et al., J Clin Med. 2019 Aug 27;8(9). pii: E1320. - Pubmed link
- Passov, A. et al.,PLoS One. 2019 Aug 15;14(8): e0221010. - Pubmed link
- Rovas, A. et al.,Crit Care. 2019 Jul 24;23(1):260. - Pubmed link
- Sharma, M. et al., Blood Res., 2018; Sep 53(3): 205-209 - Pubmed link
- Statkevicius, S. et al.,Crit Care. 2019 May 28; 23(1) :191. - Pubmed link
- Stensballe, J. et al., Anesth Analg. 2018 Oct;127(4): 920-927 - Pubmed link
- Zhu, J. et al., J Cereb Blood Flow Metab. 2018 Nov;38(11):1979-1992. - Pubmed link
- Hassani Lahsinoui, H. et al., Sci Rep. 2021; 11: 4387. - Pubmed link
- Javadi, J. et al.,Cancers (Basel) 2021 Feb; 13(4): 655. - Pubmed link
- Suzuki, K. et al., Thromb J. 2021; 19: 5. - Pubmed link
- Liew, H. et al., BMC Nephrol. 2021; 22: 21. - Pubmed link
- Fisher, J. et al., Sci Rep. 2020; 10: 18280. - Pubmed link
- Olah, C. et al., Diagnostics (Basel) 2020 Nov; 10(11): 864. - Pubmed link
- Lam, P. K. et al., Front Med (Lausanne) 2020; 7: 545813. - Pubmed link
- Rovas, A. et al., Angiogenesis. 2020 Oct 14 : 1–13. - Pubmed link
- Damén, T. et al., Acta Anaesthesiol Scand. 2021 Feb; 65(2): 220–227. - Pubmed link
- Hollósi, P. et al., Biomolecules. 2020 Oct; 10(10): 1356. - Pubmed link
- Javadi, J. et al., Biomolecules. 2020 Aug; 10(8): 1113. - Pubmed link
- Niedworok, C. et al., Transl Androl Urol. 2020 Jun; 9(3): 1167–1176. - Pubmed link
- Hahn, R. G., & Nemme, J., BMC Anesthesiol. 2020; 20: 95. - Pubmed link
- Aditianingsih, D. et al., BMC Anesthesiol. 2020; 20: 37. - Pubmed link
- Wernly, B. et al., Sci Rep. 2019; 9: 18367. - Pubmed link
- Uzawa, K. et al., J Anesth. 2020; 34(1): 36–46. - Pubmed link
- Derkacz, A. et al., J Clin Med. 2021 Apr; 10(8): 1722. - Pubmed link
- Deyab, G. et al., PLoS One. 2021; 16(7): e0253247. - Pubmed link
- Fuchs, A. et al., Blood Transfus. 2021 May; 19(3): 190–196. - Pubmed link
- Gasser, B.A. et al., Front Physiol. 2021; 12: 734111. - Pubmed link
- Goonewardena, S.N. et al., Cardiovasc Drugs Ther. 2021 Nov 18 : 1–7. - Pubmed link
- Goswami, J. et al., Shock. 2021; 56(3), 433–439. - Pubmed link
- Hulde, N. et al., J Assist Reprod Genet. 2021 Sep; 38(9): 2273–2282. - Pubmed link
- Itenov, T.S. et al., Ann Intensive Care. 2021; 11: 61. - Pubmed link
- Kitagawa, Y. et al., PLoS One. 2021; 16(12): e0260350. - Pubmed link
- Ntika, S. et al., Biomedicines. 2021 Jun; 9(6): 697. - Pubmed link
- Ogawa, F. et al., Thromb J. 2021; 19: 55. - Pubmed link
- Passov, A. et al., PLoS One. 2021; 16(5): e0251747. - Pubmed link
- Piotti, A. et al., Crit Care. 2021; 25: 113. - Pubmed link
- Reszegi, A. et al., Cancers (Basel) 2021 Apr; 13(7): 1548. - Pubmed link
- Suzuki, K. et al., Sci Rep. 2021; 11: 8864. - Pubmed link
- Vollenberg, R. et al., Viruses. 2021 Nov; 13(11): 2324. - Pubmed link
- Wang, H. et al., Microbiol Spectr. 2021 Sep-Oct; 9(2): e00042-21. - Pubmed link
- Milford, E.M. et al., Intensive Care Med Exp. 2022 Dec; 10: 34. - Pubmed link
- Mrara, B. et al., BMJ Open. 2022; 12(7): e060788. - Pubmed link
- Rovas, A. et al., Angiogenesis. 2022 Jun 20:1–13. - Pubmed link
- Henriksen, H.H. et al., Matrix Biol Plus. 2022 Aug; 15: 100115. - Pubmed link
- Drost, C.C. et al., Front Immunol. 2022; 13: 916512. - Pubmed link
- Krocker, J.D. et al., Int J Mol Sci. 2022 Jun; 23(11): 6213. - Pubmed link
- Veraldi, N. et al., J Mol Med (Berl) 2022; 100(5): 735–746. - Pubmed link
- Yablecovitch, D. et al., Clin Transl Gastroenterol. 2022 May; 13(5): e00473. - Pubmed link
- Richter, R.P. et al., Ann Surg Open. 2022 Mar;3(1):e116. - Pubmed link
- Schønemann-Lund, M. et al., Crit Care. 2022; 26: 33. - Pubmed link
- Huang, X. et al., Sci Rep. 2022; 12: 163. - Pubmed link
Related products
- 854.070.000 - Anti-Human CD138 Azide Free
- 854.073.020 - Anti-Human CD138 Unconjugated
- 854.074.010 - Anti-Human CD138 Biotinylated
- 954.071.010 - Anti-Human CD138 FITC Conjugated
- 954.072.010 - Anti-Human CD138 PE Conjugated
- 851.620.001 - Human CD138 ELISA Set
- 854.078.010 - Anti-Human CD138 PerCP Conjugated
- 853.630.000 - Anti-Human CD138 Azide Free
- 860.090.048 - Murine CD138 ELISA kit
- 861.060.001 - Murine CD138 ELISA set
BACKGROUND
Syndecans are a transmembrane protein family within the heparin sulphate proteoglycan group that interact with many different molecules of the immune system through their heparin sulphate chains. The mammalian syndecan family consists of 4 proteins; syndecan 1 to 4 each encoded by very distinct genes. In adult tissues syndecan 1 (CD138) is predominantly expressed by epithelial cells and plasma cells (both normal and malignant) and currently considered the most reliable surface marker for plasma cells. In addition CD138 is also expressed on pre and immature B cells however this is regulated by IL-6 and LPS stimulation. Syndecan 1 has previously been shown to participate in cell to cell interactions, organ development, vessel formation and tissue regeneration following injury.
CD138 is regularly cleaved from the membrane and as a consequence high levels of soluble CD138 are found in the blood, which can be easily detected using a CD138 specific ELISA.
Via its heparin sulphate chains CD138 binds to and modulates the activity of a wide range of molecules involve in inflammation including chemokines, growth factors, selectins and other adhesion molecules. CD138 can also act as a receptor for collagen, fibronectin, thromobospondin and tenascin therefore involved in cell matrix adhesion. CD138 has been shown to mediate the binding of myeloma cells to type I collagen, and inhibits tumour cell invasion into collagen gels.
As CD138 has been shown to have important effects on tumour cell growth, survival, adhesion and invasion syndecan-1 may be an important regulator in cancer biology.
Version 30 - 09.22
For research use only
For any order, the purchaser acknowledges having read and accepted the terms and conditions described on the Diaclone website.